Invention Grant
US08853376B2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
有权
稳定的适体与血小板衍生生长因子及其作为肿瘤学治疗的用途
- Patent Title: Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
- Patent Title (中): 稳定的适体与血小板衍生生长因子及其作为肿瘤学治疗的用途
-
Application No.: US13235222Application Date: 2011-09-16
-
Publication No.: US08853376B2Publication Date: 2014-10-07
- Inventor: Dilara McCauley , John L. Diener , Charles Wilson , Thomas Greene McCauley
- Applicant: Dilara McCauley , John L. Diener , Charles Wilson , Thomas Greene McCauley
- Applicant Address: US CA San Francisco
- Assignee: Archemix LLC
- Current Assignee: Archemix LLC
- Current Assignee Address: US CA San Francisco
- Agency: Cooley LLP
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04

Abstract:
Materials and methods are provided for producing and using aptamers useful as oncology therapeutics capable of binding to PDGF, PDGF isoforms, PDGF receptor, VEGF, and VEGF receptor or any combination thereof with great affinity and specificity. The compositions of the present invention are particularly useful in solid tumor therapy and can be used alone or in combination with known cytotoxic agents for the treatment of solid tumors. Also disclosed are aptamers having one or more CpG motifs embedded therein or appended thereto.
Public/Granted literature
- US20120171304A1 Stabilized Aptamers To Platelet Derived Growth Factor And Their Use As Oncology Therapeutics Public/Granted day:2012-07-05
Information query